[ad_1]
Marios Lazanas, Director – IASO Group Responsible Infectious Diseases Specialist, described the results of the Pfizer coronavirus vaccine as very encouraging, although there are no official job announcements yet.
“Pfizer reports 90% efficiency, it is a great success. The flu vaccine is 60% effective and protects us again. He also appears to be fine on side effects,” he told SKAI.
Mr. Lazanas added that it is equally important that the vaccine appears to cover older people or vulnerable groups who do not have a good ability to produce antibodies.
The downside of the new vaccine, he explained, is that it is stored at -70 or -80 degrees Celsius, as it needs special refrigerators. “Obviously, this vaccine cannot be found in pharmacies. It must be approved by the FDA (US Food and Drug Administration), and then there will be intensive production.
“This vaccine is in two doses and must be repeated in three weeks,” he said.
“A vaccine covers you so that you do not get sick.” There is a case in which nobody has very good antibodies and you get sick with much milder symptoms, in these cases you can also transmit the virus, “he said.
“I would be very happy if in the first quarter of 2021 the nursing staff and vulnerable groups could be vaccinated and then the rest. “70% of the population needs to be vaccinated so that the herd is immune; I wish we had finished in 2021 ”, he stressed.
For children, he clarified that they are the last to need vaccination, they do not get seriously ill and perhaps some age groups (minors) transmit the virus less.
As Mr. Lazanas also stressed, there is no problem in having both the COVID vaccine and the flu virus vaccine.
Regarding the second closure, he expressed particular concern and said that “I have the impression that we are not very formal in its observance.” “I think there are many more cars than the first wave.” Did we all suddenly become olive growers in Greece? “He wondered.” In my opinion, we can crash in the first days of December, “he added.
Source: skai.gr
